enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Novo Nordisk to discontinue Levemir insulin in U.S. market - AOL

    www.aol.com/news/novo-nordisk-discontinue...

    Basal insulin such as Levemir is a type of long-acting insulin injected once or twice a day as opposed to rapid, short, or intermediate-acting insulin. It is often used by people with Type 1 ...

  3. Patients push back against Novo Nordisk move to scrap an ...

    www.aol.com/news/patients-push-back-against-novo...

    Novo Nordisk's decision to stop selling its long-acting insulin Levemir in the United States has left some diabetes patients struggling to switch treatments, patients and doctors in a dozen U.S ...

  4. Novo Nordisk faces scrutiny on Capitol Hill for pulling ...

    www.aol.com/news/novo-nordisk-faces-scrutiny...

    Levemir's U.S. sales were 1.27 billion Danish crowns ($185.6 million) in 2023. Sales of Novo's other long-acting insulin Tresiba were 1.33 billion crowns last year. ($1 = 0.9172 euros)

  5. Insulin detemir - Wikipedia

    en.wikipedia.org/wiki/Insulin_detemir

    Insulin detemir, sold under the brand name Levemir among others, is a long-acting modified form of medical insulin used to treat both type 1 and type 2 diabetes. [6] It is used by injection under the skin . [ 6 ]

  6. Hypercoagulability in pregnancy - Wikipedia

    en.wikipedia.org/.../Hypercoagulability_in_pregnancy

    Hypercoagulability in pregnancy is the propensity of pregnant women to develop thrombosis (blood clots). Pregnancy itself is a factor of hypercoagulability (pregnancy-induced hypercoagulability), as a physiologically adaptive mechanism to prevent post partum bleeding . [ 1 ]

  7. Fetal warfarin syndrome - Wikipedia

    en.wikipedia.org/wiki/Fetal_warfarin_syndrome

    Fetal warfarin syndrome is a disorder of the embryo which occurs in a child whose mother took the medication warfarin (brand name: Coumadin) during pregnancy.Resulting abnormalities include low birth weight, slower growth, intellectual disability, deafness, small head size, and malformed bones, cartilage, and joints.

  8. An experimental drug drove people to lose 23% of their body ...

    www.aol.com/news/novo-nordisk-next-generation...

    CagriSema’s side effects appeared to be similar to other drugs in the GLP-1 class; the company said the most common ones were gastrointestinal, with the “vast majority” mild to moderate and ...

  9. The Zepbound Shortage Is Over — Here's What to Expect ... - AOL

    www.aol.com/zepbound-shortage-over-heres-expect...

    Eli Lilly’s weight loss drug Zepbound is no longer in short supply, the FDA said, worrying patients who use cheaper, off-brand versions of the drug. On Thursday, Dec. 19, the U.S. Food and Drug ...